-
immunotherapy using cutting-edge protein engineering with directed evolution. The lab has developed therapeutics that are currently in clinical trials, such as ST-067 (a "decoy-resistant" IL-18), MDNA-11 (CD122
-
provide fresh tumor specimens and PDX models, novel engineered murine models, state of the art-AI-enabled drug screening in microtumors and cancer cells, and more. Responsibilities The Clurman lab is
Searches related to engineering
Enter an email to receive alerts for engineering positions